Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

Saved in:
Bibliographic Details
Published in:EJD. European journal of dermatology 2021-10, Vol.31 (5), p.662-664
Main Authors: Maeda, Takuya, Hiura, Azusa, Uehara, Jiro, Toyoshima, Rino, Nakagawa, Tomoe, Yoshino, Koji
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Agents, Immunological - adverse effects
Antineoplastic Agents, Immunological - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Correspondence
Dermatology
Female
Humans
Ipilimumab - adverse effects
Ipilimumab - therapeutic use
Male
Medicine
Medicine & Public Health
Melanoma - drug therapy
Melanoma - pathology
Middle Aged
Neoplasm Staging
Nivolumab - adverse effects
Nivolumab - therapeutic use
Retrospective Studies
Skin Neoplasms - drug therapy
Skin Neoplasms - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1167-1122
1952-4013
DOI:10.1684/ejd.2021.4139